Avalo TherapeuticsAVTX
那斯達克 · USD
15.76
+0.96
(+6.49%)
收盤 01/22 04:59 (UTC+8)
01/22 04:59 (UTC+8)
Avalo TherapeuticsAVTX
15.76
+0.96
(+6.49%)
財務數據
損益表
- 0.01
- 0.00
- 0.01
- -
- -
- 0.00
- 0.00
- -
- -
- -
- 35.16
- -63.24
- 141.95
- -
- -
- -
- -22.89
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | 192 | 249 | - | - | 571 | 236 | 642 |
營業成本 | - | - | - | 87 | -716 | 343 | -80 | -221 | 246 | 708 |
營業毛利 | - | - | - | 105 | 965 | -343 | 80 | 792 | -10 | -66 |
營業費用 | 19,199 | 19,315 | 14,669 | 13,416 | - | - | - | 8,450 | 3,740 | 7,085 |
研發費用 | 13,622 | 14,072 | 9,123 | 8,183 | 9,538 | 4,600 | 2,116 | 1,867 | 1,250 | 4,659 |
推銷及管理費用 | 5,577 | 5,243 | 5,546 | 5,233 | 4,287 | 4,528 | 3,193 | 2,676 | 2,490 | 2,426 |
非經常性項目費用 | - | - | - | - | - | 103 | 27,538 | 3,907 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,199 | -19,315 | -14,669 | -13,311 | -12,860 | -9,574 | -32,767 | -7,658 | -3,750 | -7,151 |
其他收入及費用 | -11,415 | -1,434 | 1,528 | -25,231 | 34,920 | 106,906 | -88,516 | -600 | 83 | 910 |
利息費用 | - | - | - | - | - | - | - | 3,417 | 3,498 | 1,945 |
稅前純益 | -30,614 | -20,749 | -13,141 | -35,225 | 23,023 | 98,470 | -121,283 | -8,177 | -5,220 | -8,186 |
所得稅 | 11 | 16 | 8 | 114 | -14 | 7 | 7 | -9 | 8 | 7 |
稅後純益 | -30,625 | -20,765 | -13,149 | -35,339 | 23,037 | 98,463 | -121,290 | -8,168 | -5,228 | -8,193 |
基本每股稅後盈餘(元) | -2.19 | -1.92 | -1.25 | -878.18 | 0.98 | 4.21 | -141.14 | - | -0.11 | -0.59 |
稀釋每股稅後盈餘(元) | -2.29 | -1.93 | -1.25 | 1.72 | 8.00 | 110.51 | -141.14 | 117.47 | 0.45 | -0.56 |
基本平均股數(千股) | 14000.00 | 10829.00 | 10514.00 | 11295.00 | 5546.00 | 1034.00 | 859.00 | - | 46760.00 | 13970.00 |
稀釋平均股數(千股) | 14000.00 | 10829.00 | 10514.00 | 18311.00 | 10784.00 | 7653.00 | 859.00 | - | 46760.00 | 13970.00 |
還原基本每股稅後盈餘(元) | -2.19 | -1.92 | -1.25 | -878.18 | 0.98 | 4.21 | -141.14 | - | -26.83 | -140.73 |
還原稀釋每股稅後盈餘(元) | -2.29 | -1.93 | -1.25 | 1.72 | 8.00 | 110.51 | -141.14 | 117.47 | 107.80 | -134.85 |
還原基本平均股數(千股) | 14,000 | 10,829 | 10,514 | 11,295 | 5,546 | 1,034 | 859 | - | 194 | 58 |
還原稀釋平均股數(千股) | 14,000 | 10,829 | 10,514 | 18,311 | 10,784 | 7,653 | 859 | - | 194 | 58 |
EBITDA(千元) | -30,902 | -20,761 | -13,006 | -35,157 | 23,057 | 98,503 | -121,249 | -4,717 | -552 | -5,851 |